These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 19127019)

  • 21. The economics of cardiac rehabilitation and lifestyle modification: a review of literature.
    Lee AJ; Strickler GK; Shepard DS
    J Cardiopulm Rehabil Prev; 2007; 27(3):135-42. PubMed ID: 17558193
    [No Abstract]   [Full Text] [Related]  

  • 22. [Decision analytic modeling and their impact on health care decision making].
    Inotai A; Kaló Z; Mészáros A
    Acta Pharm Hung; 2009; 79(2):63-9. PubMed ID: 19634636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness in political--administrative decision-making in specialized healthcare.
    Simonen O; Vtanen E; Konu A; Blom M
    Scand J Public Health; 2009 Jul; 37(5):494-502. PubMed ID: 19506006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proposed rehabilitation research or demonstration projects: estimating target population size.
    Fuhrer MJ; Cardús D; Thrall RM
    Arch Phys Med Rehabil; 1981 Apr; 62(4):156-60. PubMed ID: 6786252
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic evaluation of nursing practices: a review of literature.
    Lämås K; Willman A; Lindholm L; Jacobsson C
    Int Nurs Rev; 2009 Mar; 56(1):13-20. PubMed ID: 19239511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of subacute rehab.
    Salcido R; Moore RW
    Rehab Manag; 1995; 8(5):33-4, 37. PubMed ID: 10166396
    [No Abstract]   [Full Text] [Related]  

  • 27. Evidence for moxifloxacin in community-acquired pneumonia: the impact of pharmaco-economic considerations on guidelines.
    Simoens S
    Curr Med Res Opin; 2009 Oct; 25(10):2447-57. PubMed ID: 19678752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lessons learned by (from?) an economist working in medical decision making.
    Wakker PP
    Med Decis Making; 2008; 28(5):690-8. PubMed ID: 18812584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.
    Hoomans T; Abrams KR; Ament AJ; Evers SM; Severens JL
    Med Care; 2009 Oct; 47(10):1053-61. PubMed ID: 19648827
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness analysis of an antimicrobial stewardship team on bloodstream infections: a probabilistic analysis.
    Scheetz MH; Bolon MK; Postelnick M; Noskin GA; Lee TA
    J Antimicrob Chemother; 2009 Apr; 63(4):816-25. PubMed ID: 19202150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Health economic decision making in Europe--a new priority for breast cancer advocacy.
    Knox S
    Breast; 2009 Apr; 18(2):71-2. PubMed ID: 19380086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Some thoughts about rehabilitation and case management: an insurer's viewpoint.
    Chernof D
    J Insur Med; 1991; 23(4):217-8. PubMed ID: 10147829
    [No Abstract]   [Full Text] [Related]  

  • 33. Hygeia or Panacea--which is the better buy?
    Lawrence RS
    Internist; 1986 Oct; 27(9):9-10. PubMed ID: 10311718
    [No Abstract]   [Full Text] [Related]  

  • 34. [A model of shared decision-making in medical rehabilitation].
    Körner M
    Rehabilitation (Stuttg); 2009 Jun; 48(3):160-5. PubMed ID: 19513957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rehabilitation from a broader health service perspective: an Australian viewpoint.
    Graham S; Cameron ID
    J Allied Health; 2009; 38(2):121-3. PubMed ID: 19623794
    [No Abstract]   [Full Text] [Related]  

  • 36. Reduction in medication costs for patients with chronic nonmalignant pain completing a pain rehabilitation program: a prospective analysis of admission, discharge, and 6-month follow-up medication costs.
    Cunningham JL; Rome JD; Kerkvliet JL; Townsend CO
    Pain Med; 2009; 10(5):787-96. PubMed ID: 19302437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Costing and perspective in published cost-effectiveness analysis.
    Neumann PJ
    Med Care; 2009 Jul; 47(7 Suppl 1):S28-32. PubMed ID: 19536023
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Conducting a cost-effectiveness trial in oncology: justification and method].
    Lejeune C; Binquet C; Bonnetain F
    Bull Cancer; 2009 May; 96(5):603-7. PubMed ID: 19435689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using and interpreting analogue designs.
    Cook BG; Rumrill PD
    Work; 2005; 24(1):93-7. PubMed ID: 15706077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
    Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.